C86.4 - Blastic NK-cell lymphoma
- Applicable to Blastic NK-cell lymphoma
- The 2025 edition of ICD10-CM C86.4 became effective on October 1, 2024.
- This is the American ICD10-CM version of C86.4 - other international versions of ICD10 C86.4 may differ.
- C86.4 is a Non-Billable / Non-Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- C86.4 Code should not be used for billing or reimbursement purposes as there are multiple ICD-10 CM codes below it that contain a greater level of detail.
- C86.4 - Blastic NK-cell lymphoma
- C86.4 - Blastic NK-cell lymphoma
- C86.40 - Blastic NK-cell lymphoma not having achieved remission
- C86.41 - Blastic NK-cell lymphoma, in remission
Inclusion terms help to clarify and specify the conditions or diseases covered by a particular ICD-10-CM code.
Inclusion Term:
- Blastic plasmacytoid dendritic cell neoplasm (BPDCN)
Non-Billable/Non-Specific Code
The following codes above C86.4 contain annotation back-references that may be applicable to C86.4:
- Chapter: C00-D49 - Neoplasms
- Section: C81-C96 - Malignant neoplasms of lymphoid, hematopoietic and related tissue
- Category: C86 - Other specified types of T/NK-cell lymphoma
Browse other similar CM codes:
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Please, give attribution to our website icd10all.com